The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Application of Radiosensitizers in Cancer Radiotherapy
Open accessAbstract
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Cancer Research Communications
(2021) · doi:10.1158/1078-0432 · Cited by 1,532
Gold Nanomaterials at Work in Biomedicine
Yang, X., Yang, M., Pang, B., Vara, M., & Xia, Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00193 · Cited by 1,162
Therapeutic efficacy of nanoparticles and routes of administration
Chenthamara, D., Subramaniam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F.-H., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,055
The growing role of precision and personalized medicine for cancer treatment
Krzyszczyk, P., Acevedo, A., Davidoff, E. J., Timmins, L. M., Marrero-Berrios, I., Patel, M., White, C., Lowe, C., Sherba, J. J., Hartmanshenn, C., et al. (2018) · TECHNOLOGY · doi:10.1142/s2339547818300020 · Cited by 698
Metallic Biomaterials: Current Challenges and Opportunities
Prasad, K., Bazaka, O., Chua, M., Rochford, M., Fedrick, L., Spoor, J., Symes, R., Tieppo, M., Collins, C., Cao, A., et al. (2017) · Materials · doi:10.3390/ma10080884 · Cited by 662
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer
Juzenas, P., Chen, W., Sun, Y.-P., Coelho, M. A. N., Generalov, R., Generalova, N., & Christensen, I. L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.004 · Cited by 610
Strategies to increase nitric oxide signalling in cardiovascular disease
Lundberg, J. O., Gladwin, M. T., & Weitzberg, E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4623 · Cited by 576
Overgaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 573
Wang, H., Mu, X., He, H., & Zhang, X.-D. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.003 · Cited by 572
Targeting Microtubules by Natural Agents for Cancer Therapy
Mukhtar, E., Adhami, V. M., & Mukhtar, H. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0791 · Cited by 565
Shahbazi, M.-A., Faghfouri, L., Ferreira, M. P. A., Figueiredo, P., Maleki, H., Sefat, F., Hirvonen, J., & Santos, H. A. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00283a · Cited by 523
Hypoxia-Modified Cancer Cell Metabolism
Al Tameemi, W., Dale, T. P., Al-Jumaily, R. M. K., & Forsyth, N. R. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00004 · Cited by 503
Zheng, L., Kelly, C. J., & Colgan, S. P. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00191.2015 · Cited by 499
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Gold nanoparticles for cancer radiotherapy: a review
Haume, K., Rosa, S., Grellet, S., Śmiałek, M. A., Butterworth, K. T., Solov’yov, A. V., Prise, K. M., Golding, J., & Mason, N. J. (2016) · Cancer Nanotechnology · doi:10.1186/s12645-016-0021-x · Cited by 445
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
X-ray-activated nanosystems for theranostic applications
Chen, X., Song, J., Chen, X., & Yang, H. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00921j · Cited by 401
Song, G., Chen, Y., Liang, C., Yi, X., Liu, J., Sun, X., Shen, S., Yang, K., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201602111 · Cited by 394
Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4449 · Cited by 380
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K., & Shasha, D. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-492 · Cited by 376
Pharmaceutical aspects of silver nanoparticles
Mathur, P., Jha, S., Ramteke, S., & Jain, N. K. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2017.1414825 · Cited by 362
Yu, X., Li, A., Zhao, C., Yang, K., Chen, X., & Li, W. (2017) · ACS Nano · doi:10.1021/acsnano.7b00476 · Cited by 339
Pandey, A. K., Singhi, E. K., Arroyo, J. P., Ikizler, T. A., Gould, E. R., Brown, J., Beckman, J. A., Harrison, D. G., & Moslehi, J. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10271 · Cited by 338
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Recent advances and future prospects of iron oxide nanoparticles in biomedicine and diagnostics
Vallabani, N. V. S., & Singh, S. (2018) · 3 Biotech · doi:10.1007/s13205-018-1286-z · Cited by 322
Aung, T., Qu, Z., Kortschak, R., & Adelson, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030656 · Cited by 319
Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3
Chendil, D., Ranga, R. S., Meigooni, D., Sathishkumar, S., & Ahmed, M. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207284 · Cited by 308
Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
Lhuillier, C., Rudqvist, N.-P., Elemento, O., Formenti, S. C., & Demaria, S. (2019) · Genome Medicine · doi:10.1186/s13073-019-0653-7 · Cited by 276
The elements of life and medicines
Chellan, P., & Sadler, P. J. (2015) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2014.0182 · Cited by 274
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Barbuti, A., & Chen, Z.-S. (2015) · Cancers · doi:10.3390/cancers7040897 · Cited by 269
Ge, Y., & Wu, Q. J. (2019) · Medical Physics · doi:10.1002/mp.13526 · Cited by 259
Nitric oxide stimulates Ca2+-independent synaptic vesicle release
Meffert, M. (1994) · Neuron · doi:10.1016/0896-6273(94)90440-5 · Cited by 255
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253
Zhang, X.-D., Luo, Z., Chen, J., Song, S., Yuan, X., Shen, X., Wang, H., Sun, Y., Gao, K., Zhang, L., et al. (2015) · Scientific Reports · doi:10.1038/srep08669 · Cited by 246
Bonvalot, S., Le Pechoux, C., De Baere, T., Kantor, G., Buy, X., Stoeckle, E., Terrier, P., Sargos, P., Coindre, J. M., Lassau, N., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1297 · Cited by 243
Toustrup, K., Sørensen, B. S., Lassen, P., Wiuf, C., Alsner, J., & Overgaard, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.010 · Cited by 221
Overgaard, J., Sand Hansen, H., Andersen, A. P., Hjelm-Hansen, M., Jørgensen, K., Sandberg, E., Berthelsen, A., Hammer, R., & Pedersen, M. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90917-6 · Cited by 214
Li, Y., Yun, K.-H., Lee, H., Goh, S.-H., Suh, Y.-G., & Choi, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.004 · Cited by 209
Semiconductor Quantum Dots for Biomedicial Applications
Shao, L., Gao, Y., & Yan, F. (2011) · Sensors · doi:10.3390/s111211736 · Cited by 204
Claes, B., Delmar, P., Yesilyurt, B. T., Reumers, J., Mazzone, M., Devlieger, R., Wildiers, H., de Haas, S., Carmeliet, P., Cutsem, E. V., et al. (2012) · Research Portal (Queen's University Belfast) · doi:10.1158/1538-7445 · Cited by 194
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
Zhang, P., Wang, L., Rodriguez-Aguayo, C., Yuan, Y., Debeb, B. G., Chen, D., Sun, Y., You, M. J., Liu, Y., Dean, D. C., et al. (2014) · Nature Communications · doi:10.1038/ncomms6671 · Cited by 187
Nanoparticle Location and Material-Dependent Dose Enhancement in X-ray Radiation Therapy
Hossain, M., & Su, M. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp306543q · Cited by 183
Radiosensitizers of hypoxic cells in solid tumours
Fowler, J. F., Adams, G. E., & Denekamp, J. (1976) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(76)80012-6 · Cited by 182
CHEMICAL RADIOSENSITIZATION OF HYPOXIC CELLS
ADAMS, G. E. (1973) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a070956 · Cited by 176
Adams, G. E., Asquith, J. C., Dewey, D. L., Foster, J. L., Michael, B. D., & Willson, R. L. (1971) · International Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine · doi:10.1080/09553007114550751 · Cited by 173
Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism
Benej, M., Hong, X., Vibhute, S., Scott, S., Wu, J., Graves, E., Le, Q.-T., Koong, A. C., Giaccia, A. J., Yu, B., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808945115 · Cited by 168
Maxwell, P. H. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.03.001 · Cited by 167
Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?
Cui, L., Her, S., Borst, G. R., Bristow, R. G., Jaffray, D. A., & Allen, C. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.007 · Cited by 164
Clinical Advances of Hypoxia-Activated Prodrugs in Combination With Radiation Therapy
Mistry, I. N., Thomas, M., Calder, E. D. D., Conway, S. J., & Hammond, E. M. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.024 · Cited by 154
Recent advances in radiation oncology
Garibaldi, C., Jereczek‐Fossa, B. A., Marvaso, G., Dicuonzo, S., Rojas, D. P., Cattani, F., Starzyńska, A., Ciardo, D., Surgo, A., Leonardi, M. C., et al. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.785 · Cited by 154
Hypoxia and hyperbaric oxygen therapy: a review
Choudhury, R. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s172460 · Cited by 153
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
Farhood, B., Goradel, N. H., Mortezaee, K., Khanlarkhani, N., Salehi, E., Nashtaei, M. S., Mirtavoos‐Mahyari, H., Motevaseli, E., Shabeeb, D., Musa, A. E., et al. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1934-0 · Cited by 151
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
Stępień, K., Ostrowski, R. P., & Matyja, E. (2016) · Medical Oncology · doi:10.1007/s12032-016-0814-0 · Cited by 148
Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment
Pinel, S., Thomas, N., Boura, C., & Barberi‐Heyob, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.013 · Cited by 148
Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
Kinsella, T. J., Dobson, P. P., Mitchell, J. B., & Fornace, A. J. (1987) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(87)90292-6 · Cited by 146
Detappe, A., Thomas, E., Tibbitt, M. W., Kunjachan, S., Zavidij, O., Parnandi, N., Reznichenko, E., Lux, F., Tillement, O., & Berbeco, R. I. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b05055 · Cited by 146
Two-dimensional transition metal dichalcogenide nanomaterials for combination cancer therapy
Gong, L., Yan, L., Zhou, R., Xie, J., Wu, W., & Gu, Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb00195a · Cited by 146
Self-citationTherapeutic potential of nitric oxide in cancer
Bonavida, B., KHINECHE, S., Huerta‐Yépez, S., & Garbán, H. (2006) · Drug Resistance Updates · doi:10.1016/j.drup.2006.05.003 · Cited by 141
Tirapazamine: From Bench to Clinical Trials
Marcu, L. G., & Olver, I. (2006) · Current Clinical Pharmacology · doi:10.2174/157488406775268192 · Cited by 138
Pajic, M., Froio, D., Daly, S., Doculara, L., Millar, E. K. A., Graham, P., Drury, A., Steinmann, A. M., de Bock, C. E., Boulghourjian, A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3105 · Cited by 136
ZnFe2O4 nanoparticles as radiosensitizers in radiotherapy of human prostate cancer cells
Meidanchi, A., Akhavan, O., Khoei, S., Shokri, A. A., Hajikarimi, Z., & Khansari, N. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2014.10.062 · Cited by 135
Duc, G. L., Roux, S., Paruta-Tuarez, A., Dufort, S., Bräuer‐Krisch, E., Marais, A., Truillet, C., Sancey, L., Perriat, P., Lux, F., et al. (2014) · Cancer Nanotechnology · doi:10.1186/s12645-014-0004-8 · Cited by 135
Misonidazole—A drug for trial in radiotherapy and oncology
Dische, S., Saunders, M. I., Flockhart, I. R., et al. (1979) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(79)90070-1 · Cited by 133
Albertella, M. R., Loadman, P. M., Jones, P. H., Phillips, R. M., Rampling, R., Burnet, N. G., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C. R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4020 · Cited by 131
Pettersen, E. O., Ebbesen, P., Gieling, R. G., Williams, K. J., Dubois, L. J., Lambin, P., Ward, C., Meehan, J., Kunkler, I. H., Langdon, S. P., et al. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.966704 · Cited by 129
Brown, J. M. (1975) · Radiation Research · doi:10.2307/3574253 · Cited by 128
Oxygen devices and delivery systems
Hardavella, G. F., Karampinis, I., Frille, A., Sreter, K. B., & Roušalová, I. (2019) · Breathe · doi:10.1183/20734735.0204-2019 · Cited by 126
Zhao, J., Liu, P., Ma, J., Li, D., Yang, H., Chen, W., & Jiang, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s224160 · Cited by 126
Clinical trials of radiosensitizers: What should we expect?
Brown, J. M. (1984) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(84)90063-4 · Cited by 123
Fang, Y., DeMarco, V. G., & Nicholl, M. B. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02272.x · Cited by 120
Cline, B., Delahunty, I. M., & Xie, J. (2018) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1541 · Cited by 118
Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Peeters, S. G. J. A., Zegers, C. M. L., Biemans, R., Lieuwes, N. G., van Stiphout, R. G. P. M., Yaromina, A., Sun, J. D., Hart, C. P., Windhorst, A. D., van Elmpt, W., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0018 · Cited by 115
Ma, N., Liu, P., He, N., Gu, N., Wu, F., & Chen, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09599 · Cited by 108
Jin, J., & Zhao, Q. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00629-y · Cited by 108
Enhanced Radiotherapy using Bismuth Sulfide Nanoagents Combined with Photo-thermal Treatment
Cheng, X., Yong, Y., Dai, Y., Song, X., Yang, G., Pan, Y., & Ge, C. (2017) · Theranostics · doi:10.7150/thno.20548 · Cited by 107
Qiu, J., Xiao, Q., Zheng, X., Zhang, L., Xing, H., Ni, D., Liu, Y., Zhang, S., Ren, Q., Hua, Y., et al. (2015) · Nano Research · doi:10.1007/s12274-015-0858-z · Cited by 106
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study
Ng, Q., Goh, V., Milner, J., Stratford, M. R. L., Folkes, L. K., Tozer, G. M., Saunders, M. I., & Hoskin, P. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70001-3 · Cited by 102
Drug radiotherapy combinations: Review of previous failures and reasons for future optimism
Higgins, G. S., O'Cathail, S. M., Muschel, R. J., & McKenna, W. G. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.12.012 · Cited by 101
Siemens, D. R., Heaton, J. P. W., Adams, M. A., Kawakami, J., & Graham, C. H. (2009) · Urology · doi:10.1016/j.urology.2009.03.004 · Cited by 100
Song, G., Chao, Y., Chen, Y., Liang, C., Yi, X., Yang, G., Yang, K., Cheng, L., Zhang, Q., & Liu, Z. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603845 · Cited by 94
miR‐144‐5p enhances the Radiosensitivity of non‐small‐cell lung Cancer cells via targeting ATF2
Song, L., Peng, L., Hua, S., Li, X., Ma, L., Jie, J., Chen, D., Wang, Y., & Li, D. (2018) · BioMed Research International · doi:10.1155/2018/5109497 · Cited by 93
Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers
Oronsky, B. T., Knox, S. J., & Scicinski, J. J. (2011) · Translational Oncology · doi:10.1593/tlo.11166 · Cited by 93
Richardson, R. B., & Harper, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7412 · Cited by 93
Luo, D., Wang, X., Zeng, S., Ramamurthy, G., Burda, C., & Basilion, J. P. (2019) · Chemical Science · doi:10.1039/c9sc02290b · Cited by 93
Nakayama, M., Sasaki, R., Ogino, C., Tanaka, T., Morita, K., Umetsu, M., Ohara, S., Tan, Z., Nishimura, Y., Akasaka, H., et al. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0666-y · Cited by 92
Yong, Y., Zhou, L., Zhang, S., Yan, L., Gu, Z., Zhang, G., & Zhao, Y. (2016) · NPG Asia Materials · doi:10.1038/am.2016.63 · Cited by 91
Dihydroartemisinin enhances radiosensitivity of human glioma cells in vitro
Kim, S. J., Kim, M. S., Lee, J. W., Lee, C. H., Yoo, H., Shin, S. H., Park, M.-J., & Lee, S. H. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0052-x · Cited by 88
Cowen, R. L., Williams, K. J., Chinje, E. C., Jaffar, M., Sheppard, F. C. D., Telfer, B. A., Wind, N. S., & Stratford, I. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2698 · Cited by 86
Relationship and interactions of curcumin with radiation therapy
Verma, V. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i3.275 · Cited by 85
Patterson, L. H., Ruparelia, K. C., McKeown, S. R., Double, J. A., Bibby, M. C., Cole, S., & Stratford, I. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1163 · Cited by 84
Cao, Y., Yang, L., Jiang, W., Wang, X., Liao, W., Tan, G., Liao, Y., Qiu, Y., Feng, D., Tang, F., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.257 · Cited by 83
Chapman, J. D., Webb, R. G., & Borsa, J. (1971) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553007114550741 · Cited by 83
Hafnia (HfO 2 ) nanoparticles as an X-ray contrast agent and mid-infrared biosensor
McGinnity, T. L., Dominguez, O., Curtis, T. E., Nallathamby, P. D., Hoffman, A. J., & Roeder, R. K. (2016) · Nanoscale · doi:10.1039/c6nr03217f · Cited by 83
High-Performance Hybrid Bismuth–Carbon Nanotube Based Contrast Agent for X-ray CT Imaging
Hernández‐Rivera, M., Kumar, I., Cho, S. Y., Cheong, B., Pulikkathara, M. X., Moghaddam, S. E., Whitmire, K. H., & Wilson, L. J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12768 · Cited by 79
MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR
Yin, H., Ma, J., Chen, L., Piao, S., Zhang, Y., Zhang, S., Ma, H., Li, Y., Qu, Y., Wang, X., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488615 · Cited by 79
Self-citationThree models of magnetic ordering in typical magnetic materials
Tang, G. D., Li, Z. Z., Ma, L., Wu, Q., Wu, L., Ge, X. S., Wu, G., & Hu, F. (2018) · Physics Reports · doi:10.1016/j.physrep.2018.06.009 · Cited by 77
Resveratrol and piperine enhance radiosensitivity of tumor cells
Tak, J. K., Lee, J. H., & Park, J.-W. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.4.242 · Cited by 76
Blood Substitutes: Evolution from Noncarrying to Oxygen- and Gas-Carrying Fluids
Cabrales, P., & Intaglietta, M. (2013) · ASAIO Journal · doi:10.1097/mat.0b013e318291fbaa · Cited by 76
Mehta, M., Basalingappa, K. M., Griffith, J. N., Andrade, D., Babu, A., Amreddy, N., Muralidharan, R., Gorospe, M., Herman, T. S., Ding, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11706 · Cited by 76
Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides
Bonnet, M., Hong, C. R., Wong, W. W., Liew, L. P., Shome, A., Wang, J., Gu, Y., Stevenson, R. J., Qi, W., Anderson, R. F., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01678 · Cited by 75
Wardman, P. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170915 · Cited by 74
Shao, Y., Song, X., Jiang, W., Chen, Y., Ning, Z., Gu, W., & Jiang, J. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.005 · Cited by 74
Synthesis and characterization of hafnium oxide nanoparticles for bio-safety
Jayaraman, V., Bhavesh, G., Chinnathambi, S., Ganesan, S., & Aruna, P. (2014) · Materials Express · doi:10.1166/mex.2014.1190 · Cited by 73
Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells
Liu, Z., Tan, H., Zhang, X., Chen, F., Zhou, Z. L., Hu, X., Chang, S., Liu, P., & Zhang, H. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1518912 · Cited by 73
Thomson, D. J., Yang, H., Baines, H., Miles, E. A., Bolton, S., West, C., & Slevin, N. J. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.03.003 · Cited by 71
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
ZHANG, Z.-S., Wang, J., SHEN, Y.-B., GUO, C.-C., Sai, K., Chen, F., MEI, X., HAN, F., & Chen, Z.-P. (2015) · Oncology Letters · doi:10.3892/ol.2015.3183 · Cited by 67
MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma
Wu, S. J., Chen, J., Wu, B., Wang, Y. J., & Guo, K. Y. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0639-5 · Cited by 67
Nitric oxide and S‐nitrosylation: excitotoxic and cell signaling mechanism
Nelson, E. J., Connolly, J. H., & McArthur, P. D. (2003) · Biology of the Cell · doi:10.1016/s0248-4900(03)00004-2 · Cited by 64
Boyle, R. G., & Travers, S. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006777698169 · Cited by 63
Semiconductor Nanoparticles as Energy Mediators for Photosensitizer-Enhanced Radiotherapy
Yang, W., Read, P. W., Mi, J., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1916 · Cited by 62
Liao, H., Kuo, C., Yang, Y., Lin, C.-P., Tai, H.-C., Chen, Y.-Y., & Chen, Y.-J. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.387 · Cited by 62
Bromma, K., Cicon, L., Beckham, W., & Chithrani, D. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68994-0 · Cited by 62
Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review
Oronsky, B. T., Knox, S. J., & Scicinski, J. J. (2012) · Translational Oncology · doi:10.1593/tlo.11307 · Cited by 59
Feng, L., Yang, D., Gai, S., He, F., Yang, G., Yang, P., & Lin, J. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.06.170 · Cited by 57
RRx-001, A novel dinitroazetidine radiosensitizer
Oronsky, B. T., Scicinski, J. J., Ning, S., Peehl, D. M., Oronsky, A. L., Cabrales, P., Bednarski, M. D., & Knox, S. J. (2016) · Investigational New Drugs · doi:10.1007/s10637-016-0326-y · Cited by 56
Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines
Schwarz, K., Dobiasch, S., Nguyen, L., Schilling, D., & Combs, S. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-60765-1 · Cited by 56
Wang, Z., Ding, Y. Y., Geng, G., & Zhu, N. (2013) · Energy Conversion and Management · doi:10.1016/j.enconman.2013.09.037 · Cited by 55
Chen, Y., Wei, M., Wang, C.-W., Lee, H.-W., Pan, S., Gao, M., Kuo, S., Cheng, A., & Teng, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.015 · Cited by 55
miRNAs in tumor radiation response: bystanders or participants?
Gandellini, P., Rancati, T., Valdagni, R., & Zaffaroni, N. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.07.004 · Cited by 54
Jayakumar, S., Patwardhan, R. S., Pal, D., Sharma, D., & Sandur, S. K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.144 · Cited by 53
Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway
Li, G., Wang, Z., Chong, T., Yang, J., Li, H., & Chen, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.148 · Cited by 53
Luo, J., Si, Z., Li, T., Li, J., Zhang, Z., Chen, G.-S., Qi, H., & Yao, H. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00189.2018 · Cited by 53
Rajaee, A., Wang, S., Zhao, L., Wang, D., Liu, Y., Wang, J., & Ying, K. (2019) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab2154 · Cited by 53
Radiation sensitization with redox modulators: A promising approach
Rosenberg, A. R., & Knox, S. J. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.10.013 · Cited by 52
Ohnishi, K., Scuric, Z., Schiestl, R. H., Okamoto, N., Takahashi, A., & Ohnishi, T. (2006) · Radiation Research · doi:10.1667/rr3606.1 · Cited by 52
Platinum nanoparticles: an exquisite tool to overcome radioresistance
Li, S., Porcel, E., Remita, H., Marco, S., Réfrégiers, M., Dutertre, M., Confalonieri, F., & Lacombe, S. (2017) · Cancer Nanotechnology · doi:10.1186/s12645-017-0028-y · Cited by 52
Liu, W., Gao, M., Tzen, K., Tsai, C., Hsu, F., Cheng, A., & Cheng, J. C. (2014) · Oncotarget · doi:10.18632/oncotarget.1978 · Cited by 50
Bourillon, L., Bourgier, C., Gaborit, N., Garambois, V., Llès, E., Zampieri, A., Ogier, C., Jarlier, M., Radosevic‐Robin, N., Orsetti, B., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32273 · Cited by 50
Salunkhe, A. B., Khot, V. M., Patil, S. I., Tofail, S. A. M., Bauer, J., & Thorat, N. D. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00077 · Cited by 50
Buchanan, I. M., Scott, T., Tandle, A. T., Burgan, W. E., Burgess, T. L., Tofilon, P. J., & Camphausen, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01122.x · Cited by 48
Brown, R., Tehei, M., Oktaria, S., Briggs, A., Stewart, C., Konstantinov, K., Rosenfeld, A. B., Corde, S., & Lerch, M. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300276 · Cited by 46
Ogawa (2009) · International Journal of Oncology · doi:10.3892/ijo_00000186 · Cited by 46
Lohse, I., Rasowski, J., Cao, P. M., Pintilie, M., Do, T., Tsao, M., Hill, R. P., & Hedley, D. W. (2016) · Oncotarget · doi:10.18632/oncotarget.9654 · Cited by 46
Gu, J., Li, Y., Zeng, J., Wang, B., Ji, K., Tang, Y., & Sun, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-07973-4 · Cited by 46
Rogers, N. M., Seeger, F., Garcin, E. D., Roberts, D. D., & Isenberg, J. S. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00134 · Cited by 45
Steward, W. P., Middleton, M. R., Benghiat, A., Loadman, P. M., Hayward, C., Waller, S., Ford, S., Halbert, G., Patterson, L. H., & Talbot, D. C. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm120 · Cited by 45
The in vitro radiosensitizer potential of resveratrol on MCF-7 breast cancer cells
Araldi, I. C. D. C., Bordin, F. P. R., Cadoná, F. C., Barbisan, F., Azzolin, V. F., Teixeira, C. F., Baumhardt, T., da Cruz, I. B. M., Duarte, M. M. M. F., & Bauermann, L. D. F. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.01.013 · Cited by 45
Hu, P., Fu, Z., Liu, G., Tan, H., Xiao, J., Shi, H., & Cheng, D. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00368 · Cited by 44
Cancer Radiotherapy: Understanding the Price of Tumor Eradication
Martin, O. A., & Martin, R. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00261 · Cited by 44
Metwally, M. A. H., Frederiksen, K. H., & Overgaard, J. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.864050 · Cited by 43
Rathnayake, S., Mongan, J., Torres, A. S., Colborn, R. E., Gao, D., Yeh, B. M., & Fu, Y. (2016) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1687 · Cited by 43
Le, Q., McCoy, J., Williamson, S. K., Ryu, J. K., Gaspar, L. E., Edelman, M. J., Dakhil, S. R., Sides, S. D., Crowley, J. J., & Gandara, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0436 · Cited by 42
The Rational Design and Biological Mechanisms of Nanoradiosensitizers
Sun, H., Wang, X., & Zhai, S. (2020) · Nanomaterials · doi:10.3390/nano10030504 · Cited by 41
The contribution of Marie Skłodowska-Curie to the development of modern oncology
Kułakowski, A. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4712-1 · Cited by 40
Wang, J., Guise, C. P., Dachs, G. U., Phung, Y., Hsu, A., Lambie, N., Patterson, A. V., & Wilson, W. R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.003 · Cited by 40
Distinct Roles of Cytochrome P450 Reductase in Mitomycin c Redox Cycling and Cytotoxicity
Wang, Y., Gray, J. P., Mishin, V. M., Heck, D. E., Laskin, D. L., & Laskin, J. D. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1098 · Cited by 40
Krüger, M., Amort, J., Wilgenbus, P., Helmstädter, J., Grechowa, I., Ebert, J., Tenzer, S., Moergel, M., Witte, I., & Horke, S. (2016) · Oncotarget · doi:10.18632/oncotarget.9013 · Cited by 40
Hu, Z., Tie, Y., Lv, G., Zhu, J., Fu, H., & Zheng, X. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4497 · Cited by 38
Walker, J. M., Rolig, A. S., Charych, D. H., Hoch, U., Kasiewicz, M. J., Rose, D. C., McNamara, M. J., Hilgart-Martiszus, I., & Redmond, W. L. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000464 · Cited by 35
Takakusagi, Y., Kishimoto, S., Naz, S., Matsumoto, S., Saito, K., Hart, C. P., Mitchell, J. B., & Krishna, M. C. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7106 · Cited by 33
Radiosensitization of Adenoid Cystic Carcinoma with MDM2 Inhibition
Prabakaran, P. J., Javaid, A. M., Swick, A. D., Werner, L. R., Nickel, K. P., Sampene, E., Hu, R., Ong, I. M., Bruce, J. Y., Hartig, G. K., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0969 · Cited by 32
Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting
Delahoussaye, Y. M., Hay, M. P., Pruijn, F. B., Denny, W. A., & Brown, J. M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00199-0 · Cited by 31
Larue, R. T. H. M., Voorde, L. V. D., Berbée, M., van Elmpt, W., Dubois, L. J., Panth, K. M., Peeters, S. G. J. A., Claessens, A., Schreurs, W. M. J., Nap, M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2709-z · Cited by 30
Cellular pharmacology of evofosfamide (TH-302): A critical re-evaluation of its bystander effects
Hong, C. R., Dickson, B. D., Jaiswal, J. K., Pruijn, F. B., Hunter, F. W., Hay, M. P., Hicks, K. O., & Wilson, W. R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.027 · Cited by 30
Jia, Y., Weng, Z., Wang, C., Zhu, M., Lu, Y., Ding, L., Wang, Y., Cheng, X., Lin, Q., & Wu, K. (2016) · Oncology Letters · doi:10.3892/ol.2016.5402 · Cited by 29
Mesa, J. E. G., Barquinero, J. F., Lee‐Estévez, M., García, O., & Casacó, A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.2.18439 · Cited by 28
Curcumin-altered p53-response genes regulate radiosensitivity in p53-mutant Ewing's sarcoma cells.
Veeraraghavan, J., Natarajan, M., Herman, T. S., & Aravindan, N. (2010) · PubMed · Cited by 28
Pushing Radiation Therapy Limitations With Theranostic Nanoparticles
Detappe, A., Lux, F., & Tillement, O. (2016) · Nanomedicine · doi:10.2217/nnm.16.38 · Cited by 20
YU, C., Yu, Y., Xu, Z., Li, H., YANG, D., XIANG, M., Zuo, Y., Li, S., Chen, Z., & Yu, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3105 · Cited by 19
Park, S. I., Park, S. J., Lee, J., Kim, H. E., Park, S. J., Sohn, J., & Park, Y. G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.122 · Cited by 19
The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy
Aiba, R. S. B., Dimova, E. Y., Görlach, A., & Kietzmann, T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.583 · Cited by 18
Ren, W., Sha, H., Yan, J., Wu, P., Yang, J. D., Li, R., Zhang, H., Yu, L., Qian, H., & Liu, B. (2018) · Journal of Biomaterials Applications · doi:10.1177/0885328218809019 · Cited by 18
Spisz, P., Zdrowowicz, M., Makurat, S., Kozak, W., Skotnicki, K., Bobrowski, K., & Rak, J. (2019) · Molecules · doi:10.3390/molecules24152819 · Cited by 18
Fathy, M. M. (2019) · BioNanoScience · doi:10.1007/s12668-019-00702-3 · Cited by 18
Luo, J., Chen, X., Chen, G., Zhou, X., Lu, X., Yang, L., Zhang, S., Zhu, W. J., & Cao, J. (2013) · Saudi Medical Journal · doi:10.15537/1658-3175.5721 · Cited by 14
Cao, F., Ju, X., Chen, D., Jiang, L., Zhu, X., Qing, S., Fang, F., Shen, Y., Jia, Z., & Zhang, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6778 · Cited by 11
Zhuang, H. M., Miao, X. L., Zhao, Z. Q., & Zhang, L. (2014) · Advanced materials research · doi:10.4028/www.scientific.net/amr.951.109 · Cited by 2
Cited by
Cancer nanotechnology: current status and perspectives
Kemp, J. A., & Kwon, Y. J. (2021) · Nano Convergence · doi:10.1186/s40580-021-00282-7 · Cited by 266
Preparation of alginate coated Pt nanoparticle for radiosensitization of breast cancer tumor
Rashidzadeh, H., Seidi, F., Ghaffarlou, M., Salehiabar, M., Charmi, J., Yaray, K., Nosrati, H., & Ertas, Y. N. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123273 · Cited by 43
A tumor cell exosome-mimicking multifunctional nanozyme for targeted breast cancer radiotherapy
Chen, G., Jiang, D., Ding, S., Huang, C., Zhu, D., & Jiang, H. (2023) · Nanoscale · doi:10.1039/d3nr03065b · Cited by 31
Nanomaterials Based on Functional Polymers for Sensitizing Cancer Radiotherapy
Lin, J., Yin, M., Liu, X., Meng, F., & Luo, L. (2022) · Macromolecular Rapid Communications · doi:10.1002/marc.202200194 · Cited by 18
Mostafavi, M., Ghazi, F., Mehrabifard, M., Alivirdiloo, V., Hajiabbasi, M., Rahimi, F., Mobed, A., Taheripak, G., Ramezani Farani, M., Huh, Y. S., et al. (2025) · Strahlentherapie und Onkologie · doi:10.1007/s00066-024-02301-y · Cited by 16
Metadata
- Authors
- Gong, L., Zhang, Y., Liu, C., Zhang, M., & Han, S.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2021-02
- Volume
- Volume 16
- Pages
- 1083-1102
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W3128691787
- Cited by
- 479
- References
- 176
- FWCI
- 41.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.